Aoxing Pharmaceutical (AXN) Breathtaking Momentum
Post# of 24
Posted On: 06/09/2015 8:11:59 AM
Shares of Aoxing Pharmaceutical Company, Inc. (AXN) soared to touch a new 52-week high in after-hours trading Monday as the company announced that the China Food and Drug Administration has issued to its subsidiary licenses to produce pain-management Tilidine Hydrochloride (HCL) tablets.
According to AXN, the company will be the sole producer of Tilidine HCL tablets in China.
Furthermore, AXN recently said that it will release very important company updates in a press conference at New York Stock Exchange on Tuesday June 09, introducing a project that the company has been working on for the past 10 years.
AXN is a U.S. incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.
More about Aoxing Pharmaceutical Company, Inc. (AXN) at www.aoxingpharma.com
**
HealthEquity, Inc. (HQY) delivered solid financial results with quarterly profit and revenue above analysts' forecasts.
For its first quarter fiscal 2016, HQY posted revenue of $29.9 million, a 48% increase year over year, and non-GAAP net income of $4.98 million, or $0.10 per diluted share, compared to non-GAAP net income of $2.72 million, or $0.06 per diluted share in the same period the prior year, exceeding the Capital IQ Consensus Estimate of $0.08 earnings per share on revenues of $28.68 million for the period
HQY has raised its full year fiscal 2016 revenue guidance to the range of $119.0 million to $123.0 million from the prior guidance range of $117.0 million to $121.0 million
HQY is one of the nation's oldest and largest dedicated health savings custodians. Its innovative technology platform and tax-advantaged accounts help members build health savings, while controlling health care costs.
More about HealthEquity, Inc. (HQY) at www.HealthEquity.com
**
Crown Equity Holdings Inc. (CRWE) provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
The company is currently developing its growing network of community targeted sites CRWE PR, expected to be a one-stop shop for the various needs of consumers.
Roxzu ( www.roxzu.com ) in development stage, is an on-line e-commerce coupon distribution channel and marketplace for merchants to create brand awareness for their business. The geo-location based mobile marketing application Roxzu is expected to be integrated in all the CRWE PR Network.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
According to AXN, the company will be the sole producer of Tilidine HCL tablets in China.
Furthermore, AXN recently said that it will release very important company updates in a press conference at New York Stock Exchange on Tuesday June 09, introducing a project that the company has been working on for the past 10 years.
AXN is a U.S. incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.
More about Aoxing Pharmaceutical Company, Inc. (AXN) at www.aoxingpharma.com
**
HealthEquity, Inc. (HQY) delivered solid financial results with quarterly profit and revenue above analysts' forecasts.
For its first quarter fiscal 2016, HQY posted revenue of $29.9 million, a 48% increase year over year, and non-GAAP net income of $4.98 million, or $0.10 per diluted share, compared to non-GAAP net income of $2.72 million, or $0.06 per diluted share in the same period the prior year, exceeding the Capital IQ Consensus Estimate of $0.08 earnings per share on revenues of $28.68 million for the period
HQY has raised its full year fiscal 2016 revenue guidance to the range of $119.0 million to $123.0 million from the prior guidance range of $117.0 million to $121.0 million
HQY is one of the nation's oldest and largest dedicated health savings custodians. Its innovative technology platform and tax-advantaged accounts help members build health savings, while controlling health care costs.
More about HealthEquity, Inc. (HQY) at www.HealthEquity.com
**
Crown Equity Holdings Inc. (CRWE) provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
The company is currently developing its growing network of community targeted sites CRWE PR, expected to be a one-stop shop for the various needs of consumers.
Roxzu ( www.roxzu.com ) in development stage, is an on-line e-commerce coupon distribution channel and marketplace for merchants to create brand awareness for their business. The geo-location based mobile marketing application Roxzu is expected to be integrated in all the CRWE PR Network.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
(0)
(0)Aoxing Pharmaceutical Company, Inc. (AOXG) Stock Research Links
Scroll down for more posts ▼